Antiplatelet drugs, coronary stents, and non-cardiac surgery

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 10, Issue 6, 2010, Pages 187-191

  DeVile, Michael P J ^a   Foëx, Pierre ^b  

^a Oxford Deanery   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649343890     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkq038     Document Type: Article

References (14)

1. Metzler H, Guber K, Kozek-Langenecker S. Anaesthesia in patients with drug-eluting stents. Curr Opin Anaesthesiol 2008; 21: 55-9.
2. Jeremias A, Sylvia B, Bridges J et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109: 1930-2.
3. Lakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
4. Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW. Coronary stents and non-cardiac surgery. Br J Anaesth 2007; 98: 560-74.
5. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49: 2145-50.
6. Burger W, Chemnitus JM, Kneissl GD. Low-dose aspirin for secondary cardiovascular prevention. Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and meta-analysis. J Intern Med 2005; 257: 399-414.
7. Van Kuijk JP, Flu WJ, Schouten O et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009; 104: 1229-34.
8. Rabbitts JA, Nuttall GA, Brown MJ et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596-604.
9. Savonitto BS, D'Urbano M, Caracciolo M et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010; doi:10.1093/bja/aep373.
10. Llau JV, Lopez-Forte C, Sapena L, Ferrandis R. Perioperative management of antiplatelet agents in non-cardiac surgery. Eur J Anaesthesiol 2009; 26: 181-7.
11. Craft RM, Chavez JJ, Bresee DC, Wortham DC, Cohen E, Carroll RC. A novel modification of the thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004; 143: 301-9.
12. Storey RF, Oldroyd KG, Wilcox RG. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndrome. Thromb Haemost 2001; 85: 401-7.
13. Kereiakes DJ, Gurbel PA. Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention. J Am Coll Cardiol Interv 2008; 1: 111-21.
14. Grines CL, Bonow RO, Casey Jr DE et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Circulation 2007; 115: 813-18.